蛋白质体学市场－全球产业规模、份额、趋势、机会和预测，按产品、技术、应用、类型、最终用户、地区和竞争细分，2020-2030 年

2024 年全球蛋白质体学市场价值为 241.1 亿美元，预计到 2030 年将达到 458.7 亿美元，预测期内的复合年增长率为 11.32%。蛋白质体学是一门大规模研究蛋白质体的学科，是至关重要的领域。蛋白质体学是一种强大的技术，用于识别与疾病相关的蛋白质并研究其产生、功能和结构。它在发现预后标记和诊断各种疾病（包括癌症、传染病、疟疾和结核病）中起着至关重要的作用。此外，在製药领域，蛋白质体学被广泛应用于阐明药物作用和毒性机制。此外，它也常用于生物标誌物的识别和验证。蛋白质体部分受底层转录组的影响，转录组包含生物体中的所有信使 RNA 分子。然而，蛋白质活性受基因表现量以外的各种因素的影响。蛋白质体学应用范围广泛。慢性病和传染病的日益普及推动了蛋白质组学产业的蓬勃发展。世界卫生组织预测，2050年，全球新增癌症病例将超过3,500万例，较2022年估计的约2,000万例激增77%。此外，疾病的流行也增加了对发病机制研究以及先进诊断和治疗方法的需求。例如，根据2024年7月发表在《自然通讯》上的一项研究，科学家利用基于蛋白质体学的方法识别了立克次体分泌的效应分子，从而了解宿主-病原体界面。

关键市场驱动因素

癌症患者数量增加

主要市场挑战

昂贵的仪器

主要市场趋势

无标记定量技术的出现

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球蛋白质体学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（试剂和分析、仪器、软体和服务）
  • 依技术（光谱学、微阵列仪器、色谱法、X 射线晶体学、蛋白质微阵列、电泳法）
  • 按应用（临床诊断、药物发现、诊断生物标记发现、其他）
  • 按类型（表达、功能、结构、计算）
  • 按最终用户（製药和生物技术公司、研究机构、CRO）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美蛋白质体学市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲蛋白质体学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太蛋白质体学市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲蛋白质体学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲蛋白质体学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球蛋白质体学市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Promega Corporation
• Agilent Technologies Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F Hoffmann-La Roche Ltd.
• Luminex Corporation

第 16 章：策略建议

第17章调查会社について・免责事项

Global Proteomics Market was valued at USD 24.11 Billion in 2024 and is expected to reach USD 45.87 Billion by 2030 with a CAGR of 11.32% during the forecast period. Proteomics, the study of proteomes on a large scale, is a crucial field. Proteomics is a powerful technique utilized for the identification of disease-associated proteins and the investigation of their production, function, and structure. It plays a crucial role in the discovery of prognostic markers and the diagnosis of various diseases, including cancer, infectious illnesses, malaria, and tuberculosis. Moreover, in the pharmaceutical sector, proteomics is extensively employed to elucidate the mechanisms of drug action and toxicity. Additionally, it is commonly applied in the identification and validation of biomarkers. The proteome is partially influenced by the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. However, protein activity is influenced by various factors beyond gene expression levels. Proteomics has a wide range of applications. The rising prevalence of chronic and infectious diseases drives proteomics industry growth. WHO predicts that there will be over 35 million new cancer cases by 2050, a 77% surge from the approximately 20 million cases estimated in 2022. Moreover, the prevalence of disease increases the demand for pathogenesis research and advanced diagnostics and therapeutics. For instance, according to research published in Nature Communications in July 2024, scientists used a proteomics-based approach to identify effectors secreted by Rickettsia spp, thereby understanding the host-pathogen interface.

Key Market Drivers

Increase In the Number of Patients Suffering from Cancer

The increasing incidence of cancer and other disorders is another crucial factor contributing to the growth of the global proteomics market. With the rising number of cancer cases worldwide, there is a pressing need for effective treatment options. This has resulted in extensive research and development in the field of life sciences, leading to significant advancements and discoveries.

One major breakthrough in this field is the characterization of human proteins, which has revolutionized the field of biomedicine. By studying gene expression at the proteome level, researchers can gain deeper insights into the intricate mechanisms underlying diseases like cancer. This constant research and development in the field of proteomics are anticipated to fuel the market's growth to a great extent. Through the application of proteomics techniques, researchers are able to extract highly significant biological information that greatly enhances our understanding of cancer biology. This knowledge can ultimately benefit patients by improving diagnosis, treatment, and overall patient care.

The continuous advancements in proteomics research not only help in identifying how proteins respond in dynamic environments, such as cancer patients, but also pave the way for the development of personalized medicine. By tailoring treatment plans based on an individual's unique proteomic profile, healthcare providers can maximize the effectiveness of therapies and minimize side effects. The increasing prevalence of cancer, along with the constant progress in proteomics research, holds immense potential for the global proteomics market. The ability to extract valuable insights from the proteome level opens up new opportunities for advancements in diagnosis, treatment, and personalized medicine, ultimately benefiting patients worldwide.

Key Market Challenges

Expensive Instruments

The need for a longer period of time in laboratories increases the cost of treatment. This is primarily due to the expensive instruments and reagents used in the process, which limits the use of this technology in developing nations. One of the most commonly used methods in proteomics is X-ray crystallography. This method involves protein expression, gene cloning, protein crystallization, and purification. However, these procedures are time-consuming, resulting in higher costs. As a result, the adoption of these procedures in developing nations is limited. This presents a significant challenge to the growth of the market and will continue to hinder its progress in the long run.

To overcome this obstacle and promote market growth in developing nations, it is crucial to expand the accessibility and affordability of these technologies. By doing so, more laboratories and research institutions in these regions will be able to utilize these advanced techniques to study proteins and contribute to scientific advancements. This, in turn, can lead to improved healthcare solutions, better understanding of diseases, and the development of targeted therapies.

Furthermore, addressing the cost issue can also encourage collaborations between developed and developing nations in the field of proteomics. By sharing resources, knowledge, and expertise, it becomes possible to overcome the financial limitations and accelerate the progress of research and innovation. This collaborative approach can create a more inclusive and globally connected scientific community, where breakthroughs in proteomics are not limited by economic constraints.

The longer time required and higher costs associated with proteomic research in laboratories pose challenges to its widespread adoption in developing nations. However, by expanding the accessibility, affordability, and fostering international collaborations, we can overcome these obstacles and promote market growth in these regions. This will not only advance scientific knowledge but also contribute to improving healthcare outcomes for people around the world.

Key Market Trends

Emergence Of Label-Free Quantification Techniques

The emergence of label-free quantification techniques is a major trend in the market. The global proteomics market has witnessed notable trends, including the rise of label-free quantification techniques. Label-free quantification, a revolutionary approach in proteomics, utilizes mass spectrometry-based methods to accurately measure proteins without the need for chemical or isotopic labels. By eliminating the use of labels, this technique offers enhanced accuracy, reproducibility, and cost-effectiveness, making it an attractive option for researchers. Moreover, label-free quantification enables the analysis of larger sample sizes, allowing for more comprehensive proteomic studies. Additionally, this approach avoids potential artifacts that may arise from labeling interference, ensuring the integrity of the protein quantification results. As the demand for high-throughput, reliable, and cost-effective proteomic analysis continues to grow, the adoption of label-free quantification techniques is expected to increase rapidly in the coming years, revolutionizing the field of proteomics and advancing our understanding of complex biological systems.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Promega Corporation
• Agilent Technologies Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F Hoffmann-La Roche Ltd.
• Luminex Corporation

Report Scope:

In this report, the Global Proteomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Proteomics Market, By Product:

• Reagents & Assays
• Instruments
• Software & Services

Proteomics Market, By Technology:

• Spectroscopy
• Microarray instruments
• Chromatography
• X-ray crystallography
• Protein Microarrays
• Electrophoresis

Proteomics Market, By Application:

• Clinical Diagnostic
• Drug Discovery
• Diagnostic Biomarker Discovery
• Others

Proteomics Market, By Type:

• Expression
• Functional
• Structural
• Computational

Proteomics Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• CROs

Proteomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Proteomics Market.

Available Customizations:

Global Proteomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Proteomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents and Assays, Instruments, Software & Services)
  • 5.2.2. By Technology (Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis)
  • 5.2.3. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
  • 5.2.4. By Type (Expression, Functional, Structural, Computational)
  • 5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Proteomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Type
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Proteomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Type
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Proteomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Type
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Proteomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Type
      • 6.3.3.2.5. By End User

7. Europe Proteomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Type
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Proteomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Type
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Proteomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Type
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Proteomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Type
      • 7.3.3.2.5. By End User
  • 7.3.4. France Proteomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Type
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Proteomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Type
      • 7.3.5.2.5. By End User

8. Asia-Pacific Proteomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Type
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Proteomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Type
      • 8.3.1.2.5. By End User
  • 8.3.2. India Proteomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Type
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Proteomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Type
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Proteomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Type
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Proteomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Type
      • 8.3.5.2.5. By End User

9. South America Proteomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Type
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Proteomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Type
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Proteomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Type
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Proteomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Type
      • 9.3.3.2.5. By End User

10. Middle East and Africa Proteomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Type
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Proteomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Type
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Proteomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Type
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Proteomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Type
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Proteomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Bruker Corporation
• 15.4. Promega Corporation
• 15.5. Agilent Technologies Inc.
• 15.6. Merck KGaA
• 15.7. Bio-Rad Laboratories, Inc.
• 15.8. Danaher Corporation
• 15.9. F Hoffmann-La Roche Ltd.
• 15.10. Luminex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer